General Information of the Compound
Compound ID
CP0378993
Compound Name
(1S,10bR)-1-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one
    Show/Hide
Structure
Formula
C14H15F3N2O
Molecular Weight
284.281
Canonical SMILES
CC[C@@H]1NCCN2[C@@H]1c1cccc(c1C2=O)C(F)(F)F
    Show/Hide
InChI
InChI=1S/C14H15F3N2O/c1-2-10-12-8-4-3-5-9(14(15,16)17)11(8)13(20)19(12)7-6-18-10/h3-5,10,12,18H,2,6-7H2,1H3/t10-,12+/m0/s1
    Show/Hide
InChIKey
IAQXADIYISFYCJ-CMPLNLGQSA-N
Physicochemical Property
logP
2.5841
Rotatable Bonds
1
Heavy Atom Count
20
Polar Areas
32.34
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
2
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16115388
ChEMBL ID
CHEMBL375302
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 126 nM
   TI
   LI
   LO
   TS
2
Ki = 91 nM
   TI
   LI
   LO
   TS
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 293 nM
   TI
   LI
   LO
   TS
2
Ki = 235 nM
   TI
   LI
   LO
   TS
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000065 HEK293-EBNA Homo sapiens (Human)  2
1
EC50 = 480 nM
   TI
   LI
   LO
   TS
2
Ki = 335 nM
   TI
   LI
   LO
   TS